View Future GrowthMyeco Group 과거 순이익 실적과거 기준 점검 0/6Myeco Group 의 수입은 연평균 -39.2%의 비율로 감소해 온 반면, Chemicals 산업은 연평균 0.4%의 비율로 증가했습니다. 매출은 연평균 17.4%의 비율로 감소해 왔습니다.핵심 정보-39.22%순이익 성장률-38.35%주당순이익(EPS) 성장률Chemicals 산업 성장률14.45%매출 성장률-17.44%자기자본이익률-48.77%순이익률-25.00%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • Aug 23Full year 2024 earnings released: AU$0.016 loss per share (vs AU$0.012 loss in FY 2023)Full year 2024 results: AU$0.016 loss per share (further deteriorated from AU$0.012 loss in FY 2023). Revenue: AU$14.4m (down 37% from FY 2023). Net loss: AU$9.42m (loss widened 40% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 25 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 25Full year 2023 earnings released: AU$0.012 loss per share (vs AU$0.006 loss in FY 2022)Full year 2023 results: AU$0.012 loss per share (further deteriorated from AU$0.006 loss in FY 2022). Revenue: AU$22.8m (down 26% from FY 2022). Net loss: AU$6.75m (loss widened 119% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.Reported Earnings • Feb 17First half 2023 earnings released: AU$0.005 loss per share (vs AU$0.001 loss in 1H 2022)First half 2023 results: AU$0.005 loss per share (further deteriorated from AU$0.001 loss in 1H 2022). Revenue: AU$11.8m (down 23% from 1H 2022). Net loss: AU$2.48m (loss widened 214% from 1H 2022). Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 8.2% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has remained flat, which means it is well ahead of earnings.Reported Earnings • Aug 27Full year 2022 earnings released: AU$0.006 loss per share (vs AU$0.005 profit in FY 2021)Full year 2022 results: AU$0.006 loss per share (down from AU$0.005 profit in FY 2021). Revenue: AU$31.0m (up 3.2% from FY 2021). Net loss: AU$3.09m (down 219% from profit in FY 2021). Over the next year, revenue is forecast to grow 28%, compared to a 12% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has increased by 90% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 14Full year 2021 earnings releasedThe company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: AU$30.1m (up 43% from FY 2020). Net income: AU$2.59m (up AU$3.78m from FY 2020). Profit margin: 8.6% (up from net loss in FY 2020). The move to profitability was driven by higher revenue.모든 업데이트 보기Recent updatesBoard Change • May 20No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. No independent directors (5 non-independent directors). Non-Executive Director Natalya Jurcheshin was the last director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.공시 • Mar 27Myeco Group Ltd announced that it expects to receive AUD 2 million in fundingMyeco Group Ltd has announced a private placement to issue Unsecured Series Two Convertible Note of the company to raise gross proceeds of AUD 2,000,000 on March 27, 2026. The transaction involves the investor participation of professional and sophisticated investors will be issued under the Company’s 15% placement capacity pursuant to ASX. The notes are 100% convertible into ordinary shares of the company at a conversion price value of AUD 0.019 per share and carry interest rate of 10.5%. The conversion price will be at a 15% discount to the VWAP over 14 trading days preceding the date of the conversion notice. The transaction is subject to approval of the board of directors of the company. The transaction is expected to close on March 31, 2026.Board Change • Dec 24No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Non-Executive Director Natalya Jurcheshin was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Sep 11Myeco Group Ltd, Annual General Meeting, Nov 13, 2025Myeco Group Ltd, Annual General Meeting, Nov 13, 2025.공시 • May 06+ 1 more updateMyeco Group Ltd announced that it expects to receive $1.6 million in fundingMyeco Group Ltd announced a private placement that it will issue unsecured convertible notes to sophisticated investors for the aggregate gross proceeds of up to $1,600,000 on May 6, 2025. The Convertible Notes accrue interest at 10.5% per annum paid quarterly over a threeyear term, and are convertible at a 15% discount to the 14-day VWAP at conversion, subject to a maximum conversion price of $0.05 and a minimum conversion price of $0.019 per share. Conversion is permitted twelve months after the draw down date, with mandatory conversion at maturity. The Company may redeem the Convertible Notes in whole or in part at any time, with 30 days notice to noteholders who may convert all or part of their outstanding principal and accrued interest during this 30 day notice period.공시 • Apr 23MyEco Group Ltd Provides an Update on Its Operational Restructure InitiativesMyEco Group Ltd. provided an update on its operational restructure initiatives. On 10 February 2025, the Company announced a strategic review of its manufacturing and production operations to support its record MyEco® branded sales growth more cost effectively, and to reposition the cost base of its manufacturing and production supply chain. The following initiatives from the operational restructure are all expected to be completed by June 2025: The ability to scale production capacity through strategic partnerships with high- end converters in south-east Asia, to reduce production costs, increase redundancy of supply chains, and increase flexibility to meet demand in different geographies - Reduced cost from the rationalisation of manufacturing assets in Malaysia - Relocation of larger pilot production equipment from Melbourne to the company's commercial plant in Nanjing, China to reduce costs for new product trials and realise efficiencies in upscaling to commercial production. Relocation of the company's head office and product development centre to lower-cost premises within Melbourne to reduce both rent and overheads The implementation of these initiatives is expected to deliver annual fixed cost savings of circa $2.5 million to $3.0 million commencing in the first quarter of fiscal year 2026. They will streamline MyEco Group's operations and scale production more efficiently with an aim to improve product margins, while minimising the requirement for capital investment. The company's fully integrated approach, utilising internal assets and key partnerships, positions MyEco Group to meet increasing demand in a cost-effective manner while maintaining the high-quality standards that the brand is known for.공시 • Feb 10+ 1 more updateMyeco Group Ltd Provides Earnings Guidance for the Second Half of Fiscal Year 2025Myeco Group Ltd. provided earnings guidance for the second half of fiscal year 2025. The Company expects its strategic repositioning and operational restructuring to reduce costs materially, with increased flexibility to scale production through the use of strategic partners better aligned to support sales growth expected in the second half of fiscal year 2025 and beyond.공시 • Sep 19SECOS Group Limited, Annual General Meeting, Nov 14, 2024SECOS Group Limited, Annual General Meeting, Nov 14, 2024.Reported Earnings • Aug 23Full year 2024 earnings released: AU$0.016 loss per share (vs AU$0.012 loss in FY 2023)Full year 2024 results: AU$0.016 loss per share (further deteriorated from AU$0.012 loss in FY 2023). Revenue: AU$14.4m (down 37% from FY 2023). Net loss: AU$9.42m (loss widened 40% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 25 percentage points per year, which is a significant difference in performance.New Risk • Aug 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (AU$13.7m market cap, or US$9.09m). Minor Risk Share price has been volatile over the past 3 months (12% average weekly change).New Risk • Jun 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: AU$14.9m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (AU$14.9m market cap, or US$9.92m).공시 • Sep 26SECOS Group Limited, Annual General Meeting, Nov 17, 2023SECOS Group Limited, Annual General Meeting, Nov 17, 2023, at 10:00 AUS Eastern Standard Time.Reported Earnings • Aug 25Full year 2023 earnings released: AU$0.012 loss per share (vs AU$0.006 loss in FY 2022)Full year 2023 results: AU$0.012 loss per share (further deteriorated from AU$0.006 loss in FY 2022). Revenue: AU$22.8m (down 26% from FY 2022). Net loss: AU$6.75m (loss widened 119% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.New Risk • Aug 18New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (AU$35.0m market cap, or US$22.4m).공시 • May 25SECOS Group Limited Appoints Natalya Jurcheshin as Non-Executive DirectorSECOS Group Limited announced the appointment of experienced company director and senior leader Natalya Jurcheshin to its Board as a Non-Executive Director. Ms Jurcheshin brings over twenty years' experience spanning finance, operations and strategy throughout Australia, North America, Ukraine and Russia in professional services, private and public companies, start-ups, and SMEs. Ms. Jurcheshin is a Non-Executive Director of Adacel Technologies Limited where she is the Chair of the Audit & Risk Management Committee and Remuneration Committee. She is a former CFO, Head of Operations and Company Secretary of Circadian Technologies Limited (renamed Opthea Limited) and is a qualified chartered accountant. Ms Jurcheshin has leadership experience in finance and accounting, risk management, strategy, operations, audit and assurance services and board roles. Her diverse commercial experience includes other senior roles with Antisense Therapeutics Limited Melbourne Symphony Orchestra, Arthur Andersen (now part of Ernst & Young) and NEISS Group Pty Ltd.공시 • Feb 20SECOS Group Limited Launches New 95% Certified Recycled MyEcoBagThe Board of SECOS Group Limited provided the market with an update on the launch of its new 95% Certified Recycled MyEco range of products. SECOS Group Limited launches a new recycled MyEco bin liner range produced from 95% soft-plastic Post-Consumer Waste which has been certified to meet Global Recycle Standards for recycling content, chain of custody, social and environmental practices, and chemical restrictions. Unlike many recycled products that are not produced from Post- Consumer Waste, MyEc recycled products offer a genuine recycling solution for soft plastics without compromising quality. The products will be offered for sale as part of the Group's MyEco range of products and will target the growing recycled product market segment, to reduce the amount of virgin plastic finding its way into environment and to reduce petroleum consumption and CO2 emissions. SECOS Group, an Australian company, will produce the MyEco 95% Recycled range in the Company's Asian manufacturing plants. The expanded range further aligns SECOS insupporting the Australian Government's environmental policy of "Reuse, Recycle or Compost" as stated in the Australian National Plastic Plan and mirrors policy in many other key markets around the world in the fight to reducing the amount of single use plastic in environment.Reported Earnings • Feb 17First half 2023 earnings released: AU$0.005 loss per share (vs AU$0.001 loss in 1H 2022)First half 2023 results: AU$0.005 loss per share (further deteriorated from AU$0.001 loss in 1H 2022). Revenue: AU$11.8m (down 23% from 1H 2022). Net loss: AU$2.48m (loss widened 214% from 1H 2022). Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 8.2% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has remained flat, which means it is well ahead of earnings.공시 • Jan 27+ 1 more updateSECOS Group Limited Announces CEO ChangesSECOS Group Limited announced changes to its CEO Position. Current SECOS Executive Chairman, Mr. Richard Tegoni will take on the role of CEO. The changes will be effective from 1 February 2023. After four years as SECOS CEO, Mr. Ian Stacey will step down to focus on sales and strategic partnership development including working with Industry participants and corporate development opportunities. Mr. Tegoni has served as Executive Chairman on the SECOS Board since October 2013 and brings over ten years' experience in the biopolymer industry together with experience in several senior executive roles across a range of industries. Mr. Tegoni was a very early-stage investor into the biopolymer industry and has guided the business from a small start up to become a global player in compostable products and technology making him an ideal person to take the helm as CEO and lead the Company on its next stage of growth.Board Change • Nov 17No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. No independent directors (4 non-independent directors). Non-Executive Director Jim Walsh was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Aug 27Full year 2022 earnings released: AU$0.006 loss per share (vs AU$0.005 profit in FY 2021)Full year 2022 results: AU$0.006 loss per share (down from AU$0.005 profit in FY 2021). Revenue: AU$31.0m (up 3.2% from FY 2021). Net loss: AU$3.09m (down 219% from profit in FY 2021). Over the next year, revenue is forecast to grow 28%, compared to a 12% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has increased by 90% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.Board Change • Jul 12No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. No independent directors (5 non-independent directors). Non-Executive Director Jim Walsh was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Aug 14Full year 2021 earnings releasedThe company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: AU$30.1m (up 43% from FY 2020). Net income: AU$2.59m (up AU$3.78m from FY 2020). Profit margin: 8.6% (up from net loss in FY 2020). The move to profitability was driven by higher revenue.Breakeven Date Change • Jun 30Forecast breakeven pushed back to 2022The analyst covering SECOS Group previously expected the company to break even in 2021. New forecast suggests the company will make a profit of AU$5.70m in 2022. Average annual earnings growth of 103% is required to achieve expected profit on schedule.Recent Insider Transactions • Mar 04Executive Director recently bought AU$307k worth of stockOn the 2nd of March, Stephen Walters bought around 1m shares on-market at roughly AU$0.31 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold AU$636k more in shares than they bought in the last 12 months.Analyst Estimate Surprise Post Earnings • Feb 23Revenue beats expectationsRevenue exceeded analyst estimates by 3.4%. Over the next year, revenue is forecast to grow 50%, compared to a 15% growth forecast for the Chemicals industry in Australia.Is New 90 Day High Low • Feb 09New 90-day high: AU$0.34The company is up 113% from its price of AU$0.16 on 11 November 2020. The Australian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.50 per share.Recent Insider Transactions • Feb 05Executive Chairman recently bought AU$60k worth of stockOn the 4th of February, Richard Tegoni bought around 200k shares on-market at roughly AU$0.30 per share. This was the largest purchase by an insider in the last 3 months. This was Richard's only on-market trade for the last 12 months.Is New 90 Day High Low • Jan 21New 90-day high: AU$0.24The company is up 53% from its price of AU$0.16 on 23 October 2020. The Australian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.49 per share.Is New 90 Day High Low • Jan 06New 90-day high: AU$0.21The company is up 26% from its price of AU$0.17 on 09 October 2020. The Australian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.50 per share.Is New 90 Day High Low • Nov 19New 90-day high: AU$0.20The company is up 24% from its price of AU$0.17 on 21 August 2020. The Australian market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.46 per share.매출 및 비용 세부 내역Myeco Group가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이CHIA:MCO 매출, 비용 및 순이익 (AUD Millions)날짜매출순이익일반관리비연구개발비31 Dec 2516-47030 Sep 2516-48030 Jun 2516-58031 Mar 2516-78031 Dec 2416-98030 Sep 2415-97030 Jun 2414-97031 Mar 2414-87031 Dec 2314-77030 Sep 2315-77030 Jun 2316-67031 Mar 2320-66031 Dec 2223-56030 Sep 2227-46030 Jun 2231-36031 Mar 2231-15031 Dec 213225030 Sep 213125030 Jun 213034031 Mar 212714031 Dec 202404030 Sep 2023-14030 Jun 2021-14031 Mar 2021-24031 Dec 1921-24030 Sep 1921-35030 Jun 1921-46031 Mar 1922-46031 Dec 1823-46030 Sep 1823-46030 Jun 1824-36031 Mar 1823-35031 Dec 1723-35030 Sep 1723-35030 Jun 1722-35031 Dec 1621-45030 Sep 1621-45030 Jun 1621-55031 Dec 1519-44130 Sep 1518-43030 Jun 1517-330양질의 수익: MCO 은(는) 현재 수익성이 없습니다.이익 마진 증가: MCO는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: MCO은 수익성이 없으며 지난 5년 동안 손실이 연평균 39.2% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 MCO의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: MCO은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(6.2%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: MCO는 현재 수익성이 없으므로 자본 수익률이 음수(-48.77%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/16 11:07종가2026/06/16 00:00수익2025/12/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Myeco Group Ltd는 2명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Aaron MullerCanaccord GenuityHeath AndrewsPAC Partners Securities Pty. Ltd.
Reported Earnings • Aug 23Full year 2024 earnings released: AU$0.016 loss per share (vs AU$0.012 loss in FY 2023)Full year 2024 results: AU$0.016 loss per share (further deteriorated from AU$0.012 loss in FY 2023). Revenue: AU$14.4m (down 37% from FY 2023). Net loss: AU$9.42m (loss widened 40% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 25 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 25Full year 2023 earnings released: AU$0.012 loss per share (vs AU$0.006 loss in FY 2022)Full year 2023 results: AU$0.012 loss per share (further deteriorated from AU$0.006 loss in FY 2022). Revenue: AU$22.8m (down 26% from FY 2022). Net loss: AU$6.75m (loss widened 119% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.
Reported Earnings • Feb 17First half 2023 earnings released: AU$0.005 loss per share (vs AU$0.001 loss in 1H 2022)First half 2023 results: AU$0.005 loss per share (further deteriorated from AU$0.001 loss in 1H 2022). Revenue: AU$11.8m (down 23% from 1H 2022). Net loss: AU$2.48m (loss widened 214% from 1H 2022). Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 8.2% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
Reported Earnings • Aug 27Full year 2022 earnings released: AU$0.006 loss per share (vs AU$0.005 profit in FY 2021)Full year 2022 results: AU$0.006 loss per share (down from AU$0.005 profit in FY 2021). Revenue: AU$31.0m (up 3.2% from FY 2021). Net loss: AU$3.09m (down 219% from profit in FY 2021). Over the next year, revenue is forecast to grow 28%, compared to a 12% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has increased by 90% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 14Full year 2021 earnings releasedThe company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: AU$30.1m (up 43% from FY 2020). Net income: AU$2.59m (up AU$3.78m from FY 2020). Profit margin: 8.6% (up from net loss in FY 2020). The move to profitability was driven by higher revenue.
Board Change • May 20No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. No independent directors (5 non-independent directors). Non-Executive Director Natalya Jurcheshin was the last director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
공시 • Mar 27Myeco Group Ltd announced that it expects to receive AUD 2 million in fundingMyeco Group Ltd has announced a private placement to issue Unsecured Series Two Convertible Note of the company to raise gross proceeds of AUD 2,000,000 on March 27, 2026. The transaction involves the investor participation of professional and sophisticated investors will be issued under the Company’s 15% placement capacity pursuant to ASX. The notes are 100% convertible into ordinary shares of the company at a conversion price value of AUD 0.019 per share and carry interest rate of 10.5%. The conversion price will be at a 15% discount to the VWAP over 14 trading days preceding the date of the conversion notice. The transaction is subject to approval of the board of directors of the company. The transaction is expected to close on March 31, 2026.
Board Change • Dec 24No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Non-Executive Director Natalya Jurcheshin was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Sep 11Myeco Group Ltd, Annual General Meeting, Nov 13, 2025Myeco Group Ltd, Annual General Meeting, Nov 13, 2025.
공시 • May 06+ 1 more updateMyeco Group Ltd announced that it expects to receive $1.6 million in fundingMyeco Group Ltd announced a private placement that it will issue unsecured convertible notes to sophisticated investors for the aggregate gross proceeds of up to $1,600,000 on May 6, 2025. The Convertible Notes accrue interest at 10.5% per annum paid quarterly over a threeyear term, and are convertible at a 15% discount to the 14-day VWAP at conversion, subject to a maximum conversion price of $0.05 and a minimum conversion price of $0.019 per share. Conversion is permitted twelve months after the draw down date, with mandatory conversion at maturity. The Company may redeem the Convertible Notes in whole or in part at any time, with 30 days notice to noteholders who may convert all or part of their outstanding principal and accrued interest during this 30 day notice period.
공시 • Apr 23MyEco Group Ltd Provides an Update on Its Operational Restructure InitiativesMyEco Group Ltd. provided an update on its operational restructure initiatives. On 10 February 2025, the Company announced a strategic review of its manufacturing and production operations to support its record MyEco® branded sales growth more cost effectively, and to reposition the cost base of its manufacturing and production supply chain. The following initiatives from the operational restructure are all expected to be completed by June 2025: The ability to scale production capacity through strategic partnerships with high- end converters in south-east Asia, to reduce production costs, increase redundancy of supply chains, and increase flexibility to meet demand in different geographies - Reduced cost from the rationalisation of manufacturing assets in Malaysia - Relocation of larger pilot production equipment from Melbourne to the company's commercial plant in Nanjing, China to reduce costs for new product trials and realise efficiencies in upscaling to commercial production. Relocation of the company's head office and product development centre to lower-cost premises within Melbourne to reduce both rent and overheads The implementation of these initiatives is expected to deliver annual fixed cost savings of circa $2.5 million to $3.0 million commencing in the first quarter of fiscal year 2026. They will streamline MyEco Group's operations and scale production more efficiently with an aim to improve product margins, while minimising the requirement for capital investment. The company's fully integrated approach, utilising internal assets and key partnerships, positions MyEco Group to meet increasing demand in a cost-effective manner while maintaining the high-quality standards that the brand is known for.
공시 • Feb 10+ 1 more updateMyeco Group Ltd Provides Earnings Guidance for the Second Half of Fiscal Year 2025Myeco Group Ltd. provided earnings guidance for the second half of fiscal year 2025. The Company expects its strategic repositioning and operational restructuring to reduce costs materially, with increased flexibility to scale production through the use of strategic partners better aligned to support sales growth expected in the second half of fiscal year 2025 and beyond.
공시 • Sep 19SECOS Group Limited, Annual General Meeting, Nov 14, 2024SECOS Group Limited, Annual General Meeting, Nov 14, 2024.
Reported Earnings • Aug 23Full year 2024 earnings released: AU$0.016 loss per share (vs AU$0.012 loss in FY 2023)Full year 2024 results: AU$0.016 loss per share (further deteriorated from AU$0.012 loss in FY 2023). Revenue: AU$14.4m (down 37% from FY 2023). Net loss: AU$9.42m (loss widened 40% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 25 percentage points per year, which is a significant difference in performance.
New Risk • Aug 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (AU$13.7m market cap, or US$9.09m). Minor Risk Share price has been volatile over the past 3 months (12% average weekly change).
New Risk • Jun 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: AU$14.9m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (AU$14.9m market cap, or US$9.92m).
공시 • Sep 26SECOS Group Limited, Annual General Meeting, Nov 17, 2023SECOS Group Limited, Annual General Meeting, Nov 17, 2023, at 10:00 AUS Eastern Standard Time.
Reported Earnings • Aug 25Full year 2023 earnings released: AU$0.012 loss per share (vs AU$0.006 loss in FY 2022)Full year 2023 results: AU$0.012 loss per share (further deteriorated from AU$0.006 loss in FY 2022). Revenue: AU$22.8m (down 26% from FY 2022). Net loss: AU$6.75m (loss widened 119% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.
New Risk • Aug 18New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (AU$35.0m market cap, or US$22.4m).
공시 • May 25SECOS Group Limited Appoints Natalya Jurcheshin as Non-Executive DirectorSECOS Group Limited announced the appointment of experienced company director and senior leader Natalya Jurcheshin to its Board as a Non-Executive Director. Ms Jurcheshin brings over twenty years' experience spanning finance, operations and strategy throughout Australia, North America, Ukraine and Russia in professional services, private and public companies, start-ups, and SMEs. Ms. Jurcheshin is a Non-Executive Director of Adacel Technologies Limited where she is the Chair of the Audit & Risk Management Committee and Remuneration Committee. She is a former CFO, Head of Operations and Company Secretary of Circadian Technologies Limited (renamed Opthea Limited) and is a qualified chartered accountant. Ms Jurcheshin has leadership experience in finance and accounting, risk management, strategy, operations, audit and assurance services and board roles. Her diverse commercial experience includes other senior roles with Antisense Therapeutics Limited Melbourne Symphony Orchestra, Arthur Andersen (now part of Ernst & Young) and NEISS Group Pty Ltd.
공시 • Feb 20SECOS Group Limited Launches New 95% Certified Recycled MyEcoBagThe Board of SECOS Group Limited provided the market with an update on the launch of its new 95% Certified Recycled MyEco range of products. SECOS Group Limited launches a new recycled MyEco bin liner range produced from 95% soft-plastic Post-Consumer Waste which has been certified to meet Global Recycle Standards for recycling content, chain of custody, social and environmental practices, and chemical restrictions. Unlike many recycled products that are not produced from Post- Consumer Waste, MyEc recycled products offer a genuine recycling solution for soft plastics without compromising quality. The products will be offered for sale as part of the Group's MyEco range of products and will target the growing recycled product market segment, to reduce the amount of virgin plastic finding its way into environment and to reduce petroleum consumption and CO2 emissions. SECOS Group, an Australian company, will produce the MyEco 95% Recycled range in the Company's Asian manufacturing plants. The expanded range further aligns SECOS insupporting the Australian Government's environmental policy of "Reuse, Recycle or Compost" as stated in the Australian National Plastic Plan and mirrors policy in many other key markets around the world in the fight to reducing the amount of single use plastic in environment.
Reported Earnings • Feb 17First half 2023 earnings released: AU$0.005 loss per share (vs AU$0.001 loss in 1H 2022)First half 2023 results: AU$0.005 loss per share (further deteriorated from AU$0.001 loss in 1H 2022). Revenue: AU$11.8m (down 23% from 1H 2022). Net loss: AU$2.48m (loss widened 214% from 1H 2022). Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 8.2% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
공시 • Jan 27+ 1 more updateSECOS Group Limited Announces CEO ChangesSECOS Group Limited announced changes to its CEO Position. Current SECOS Executive Chairman, Mr. Richard Tegoni will take on the role of CEO. The changes will be effective from 1 February 2023. After four years as SECOS CEO, Mr. Ian Stacey will step down to focus on sales and strategic partnership development including working with Industry participants and corporate development opportunities. Mr. Tegoni has served as Executive Chairman on the SECOS Board since October 2013 and brings over ten years' experience in the biopolymer industry together with experience in several senior executive roles across a range of industries. Mr. Tegoni was a very early-stage investor into the biopolymer industry and has guided the business from a small start up to become a global player in compostable products and technology making him an ideal person to take the helm as CEO and lead the Company on its next stage of growth.
Board Change • Nov 17No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. No independent directors (4 non-independent directors). Non-Executive Director Jim Walsh was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Aug 27Full year 2022 earnings released: AU$0.006 loss per share (vs AU$0.005 profit in FY 2021)Full year 2022 results: AU$0.006 loss per share (down from AU$0.005 profit in FY 2021). Revenue: AU$31.0m (up 3.2% from FY 2021). Net loss: AU$3.09m (down 219% from profit in FY 2021). Over the next year, revenue is forecast to grow 28%, compared to a 12% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has increased by 90% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.
Board Change • Jul 12No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. No independent directors (5 non-independent directors). Non-Executive Director Jim Walsh was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Aug 14Full year 2021 earnings releasedThe company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: AU$30.1m (up 43% from FY 2020). Net income: AU$2.59m (up AU$3.78m from FY 2020). Profit margin: 8.6% (up from net loss in FY 2020). The move to profitability was driven by higher revenue.
Breakeven Date Change • Jun 30Forecast breakeven pushed back to 2022The analyst covering SECOS Group previously expected the company to break even in 2021. New forecast suggests the company will make a profit of AU$5.70m in 2022. Average annual earnings growth of 103% is required to achieve expected profit on schedule.
Recent Insider Transactions • Mar 04Executive Director recently bought AU$307k worth of stockOn the 2nd of March, Stephen Walters bought around 1m shares on-market at roughly AU$0.31 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold AU$636k more in shares than they bought in the last 12 months.
Analyst Estimate Surprise Post Earnings • Feb 23Revenue beats expectationsRevenue exceeded analyst estimates by 3.4%. Over the next year, revenue is forecast to grow 50%, compared to a 15% growth forecast for the Chemicals industry in Australia.
Is New 90 Day High Low • Feb 09New 90-day high: AU$0.34The company is up 113% from its price of AU$0.16 on 11 November 2020. The Australian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.50 per share.
Recent Insider Transactions • Feb 05Executive Chairman recently bought AU$60k worth of stockOn the 4th of February, Richard Tegoni bought around 200k shares on-market at roughly AU$0.30 per share. This was the largest purchase by an insider in the last 3 months. This was Richard's only on-market trade for the last 12 months.
Is New 90 Day High Low • Jan 21New 90-day high: AU$0.24The company is up 53% from its price of AU$0.16 on 23 October 2020. The Australian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.49 per share.
Is New 90 Day High Low • Jan 06New 90-day high: AU$0.21The company is up 26% from its price of AU$0.17 on 09 October 2020. The Australian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.50 per share.
Is New 90 Day High Low • Nov 19New 90-day high: AU$0.20The company is up 24% from its price of AU$0.17 on 21 August 2020. The Australian market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.46 per share.